https://new.immunopaedia.com/wp-content/uploads/2025/03/Prankur-Awasthi.jpeg
What is your name?
Prankur Awasthi
What is your current position?
PhD student
Which institute and country do you work in?
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow, INDIA
What is your home country?
India
What are your research interests?
EBV-driven lymphoma, Immuno-oncology and T-cell exhaustion, Cancer epigenetic regulation
Tell us about yourself and your research interests:
I am a PhD research scholar at the Amity Institute of Biotechnology, Amity University Uttar Pradesh, specializing in Epstein-Barr Virus (EBV)-associated diffuse large B-cell lymphoma (DLBCL). My research focuses on understanding the molecular mechanisms driving EBV-related cancers, particularly immune evasion, biomarker discovery, and therapeutic resistance.
My expertise includes molecular biology techniques such as qRT-PCR, flow cytometry, CRISPR-Cas9, and in vitro assays like MTT and ROS detection. I integrate bioinformatics and multi-omics approaches to identify potential therapeutic targets in EBV-driven malignancies.
I have actively participated in international conferences, including IUIS-FIMSA-IIS Immuno-India 2023 and 2024, where I explored epigenetic regulation in immune responses. My contributions to cancer research have been recognized with awards such as the Young Scientist Award (SERB, Govt. of India) and the FIMSA Travel Award.
My goal is to contribute to precision oncology by developing targeted therapeutic strategies for EBV-associated lymphomas, ultimately improving patient outcomes.
What are your online profiles?
LinkedIn – Prankur Awasthi
Immunology Keywords:
B-cell lymphoma, immune evasion, epigenetic regulation
